Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Adrenocortical cancer (ACC) is a rarely diagnosed and aggressive cancer whose metastatic form has been scarcely studied. Here, the authors study primary and metastatic ACC to investigate genomic heterogeneity, discovering higher mutation rates in metastatic lesions and novel recurrent mutations.
Guardado en:
Autores principales: | Sudheer Kumar Gara, Justin Lack, Lisa Zhang, Emerson Harris, Margaret Cam, Electron Kebebew |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c5675233ee343b3b700e4345c1632f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
To the editor
por: Electron Kebebew, et al.
Publicado: (2017) -
Differentially expressed proteins in malignant and benign adrenocortical tumors.
por: Hanna Kjellin, et al.
Publicado: (2014) -
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors
por: Pál Perge, et al.
Publicado: (2017) -
Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?
por: Cristina L Ronchi, et al.
Publicado: (2013) -
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
por: Lauren Brady, et al.
Publicado: (2021)